Related Experiment Video
Updated: Feb 6, 2026

Exploring the Root Microbiome: Extracting Bacterial Community Data from the Soil, Rhizosphere, and Root Endosphere
Published on: May 2, 2018
Astragalus Root dry extract restores connexin43 expression by targeting miR-1 in viral myocarditis
Yu Wang1, Jian Li2, Liying Xuan1
1Medicinal Chemistry and Pharmacology Institute, Inner Mongolia University for Nationalities, Tongliao, Inner Mongolia, PR China; Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System, Tongliao, Inner Mongolia, PR China.
Insights
Astragalus Root dry extract (ARDE) prevents viral myocarditis-induced arrhythmia in mice by regulating miR-1 and Cx43 expression. This study reveals ARDE
Area of Science:
- Cardiology
- Virology
- Molecular Biology
Background:
- Viral myocarditis, a myocardial infection, impairs heart function and leads to heart failure.
- Arrhythmia is a significant complication of viral myocarditis, increasing mortality.
- Current treatments for viral infection and associated arrhythmia are limited.
Purpose of the Study:
- To investigate the therapeutic effects of Astragalus Root dry extract (ARDE) on Coxsackievirus B3 (CVB3)-induced arrhythmia in a mouse model.
- To elucidate the underlying molecular mechanisms of ARDE's action, focusing on the Cx43 and miR-1 pathway.
Main Methods:
- Mice and HL-1 cells were infected with CVB3 and treated with ARDE.
- The reciprocal regulation between Cx43 and miR-1 was analyzed in infected myocardium and HL-1 cells.
- Luciferase reporter assays were used to confirm the interaction between miR-1 and Cx43 mRNA.
Main Results:
- CVB3 infection induced immune cell infiltration and arrhythmia in mice.
- ARDE treatment significantly reduced immune cell infiltration and prevented arrhythmia.
- CVB3 infection elevated miR-1 levels, suppressing Cx43 expression, while ARDE attenuated this effect.
- Overexpression of miR-1 inhibited Cx43 expression, and loss-of-function of miR-1 restored Cx43 levels.
Conclusions:
- CVB3 infection reduces Cx43 expression by increasing miR-1 levels in viral myocarditis.
- ARDE demonstrates a novel therapeutic potential for preventing arrhythmia in viral myocarditis.
- ARDE rescues CVB3-induced Cx43 downregulation via modulation of miR-1 levels.
Background:
Viral myocarditis is defined as viral infection of myocardial tissue leading to impaired heart function and heart failure. Accumulating evidences have shown that arrhythmia is one of important complicating diseases of viral myocarditis causing increased mortality and morbidity. There are no effective treatment for the viral infection and complicating arrhythmia.
Purpose:
This study investigated the effect and mechanism of Astragalus Root dry extract (ARDE) on arrhythmia induced by CVB3 in mice.
Methods:
The mice and HL-1 cells were treated with CVB3 and ARDE. Reciprocal regulation of Cx43 and miR-1 were observed in the CVB3 infected mouse myocardium and culture HL-1 cells.
Results:
CVB3 IP injection increased immune cell infiltration in mouse left ventricle and caused irregular arrhythmia. ARDE treatment prevented the increase of immune cell infiltration and arrhythmia. Overexpression of miR-1 significantly inhibited both endogenous Cx43 expression and Cx43 3'UTR luciferase activity in HL-1 cells. Mutation of census binding site of +1586-1593 bp not +465-472 bp in Cx43 3'UTR luciferase resulted in abolishment of miR-1 inhibitory effects in HL-1 cells. Loss-of- function of miR-1 restored CVB3-induced Cx43 expression reduction in cultured HL-1 cells. The presence of ARDE attenuated the augmented miR-1 induced by CVB3 infection in vivo and in vitro.
Conclusion:
This study identified that CVB3 infection reduced Cx43 expression by elevating miR-1 level in mouse viral myocarditis. For the first time, ARDE was shown to prevent arrhythmia, and rescue CVB3-induced endogenous Cx43 expression by regulating miR-1 level.
More Related Videos
Related Concept Videos
Restorative Care
Myocarditis I: Introduction
Myocarditis IV: Nursing Management
Viral Recombination
Myocarditis III: Medical Management
Viral Structure

